LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,253 | -49.7% | 338 | -39.5% | 0.00% | – |
| Q2 2023 | $40,304 | -51.6% | 559 | -50.6% | 0.00% | – |
| Q1 2023 | $83,270 | +204.0% | 1,132 | +176.1% | 0.00% | – |
| Q4 2022 | $27,388 | -60.9% | 410 | -49.3% | 0.00% | – |
| Q3 2022 | $70,000 | +1.4% | 808 | +4.1% | 0.00% | – |
| Q2 2022 | $69,000 | -48.9% | 776 | -35.5% | 0.00% | – |
| Q1 2022 | $135,000 | +110.9% | 1,204 | +187.4% | 0.00% | – |
| Q4 2021 | $64,000 | +8.5% | 419 | -0.9% | 0.00% | – |
| Q3 2021 | $59,000 | -60.1% | 423 | -62.4% | 0.00% | – |
| Q2 2021 | $148,000 | -12.4% | 1,125 | +1.4% | 0.00% | – |
| Q1 2021 | $169,000 | +87.8% | 1,110 | +22.8% | 0.00% | – |
| Q4 2020 | $90,000 | -15.9% | 904 | -18.8% | 0.00% | – |
| Q3 2020 | $107,000 | -77.3% | 1,113 | -73.6% | 0.00% | – |
| Q2 2020 | $472,000 | -43.3% | 4,222 | -63.1% | 0.00% | – |
| Q1 2020 | $832,000 | -86.0% | 11,455 | -79.9% | 0.00% | -100.0% |
| Q4 2019 | $5,957,000 | -8.8% | 57,114 | -13.0% | 0.00% | 0.0% |
| Q3 2019 | $6,533,000 | -55.0% | 65,631 | -48.4% | 0.00% | -50.0% |
| Q2 2019 | $14,532,000 | -58.6% | 127,302 | -54.5% | 0.00% | -50.0% |
| Q1 2019 | $35,136,000 | -23.6% | 279,505 | -17.5% | 0.00% | -33.3% |
| Q4 2018 | $45,994,000 | -68.8% | 338,944 | -36.8% | 0.01% | -64.7% |
| Q3 2018 | $147,300,000 | +61.4% | 536,632 | +21.8% | 0.02% | +54.5% |
| Q2 2018 | $91,276,000 | +29.6% | 440,584 | +3.3% | 0.01% | +37.5% |
| Q1 2018 | $70,452,000 | +19.7% | 426,567 | -0.8% | 0.01% | +14.3% |
| Q4 2017 | $58,864,000 | -18.7% | 429,884 | -19.2% | 0.01% | -22.2% |
| Q3 2017 | $72,443,000 | +48.7% | 532,085 | +32.6% | 0.01% | +50.0% |
| Q2 2017 | $48,707,000 | +8.5% | 401,213 | -5.4% | 0.01% | 0.0% |
| Q1 2017 | $44,883,000 | -9.1% | 424,063 | -12.8% | 0.01% | -14.3% |
| Q4 2016 | $49,389,000 | -49.6% | 486,063 | -49.4% | 0.01% | -46.2% |
| Q3 2016 | $97,984,000 | -22.2% | 960,063 | -9.0% | 0.01% | -23.5% |
| Q2 2016 | $125,885,000 | +20.5% | 1,055,463 | +8.2% | 0.02% | +21.4% |
| Q1 2016 | $104,441,000 | -13.3% | 975,263 | -12.2% | 0.01% | -12.5% |
| Q4 2015 | $120,407,000 | +35.2% | 1,110,563 | +6.8% | 0.02% | +23.1% |
| Q3 2015 | $89,064,000 | -13.4% | 1,039,862 | +2.0% | 0.01% | 0.0% |
| Q2 2015 | $102,841,000 | +31.4% | 1,019,232 | +0.4% | 0.01% | +30.0% |
| Q1 2015 | $78,289,000 | +54.9% | 1,015,292 | +6.9% | 0.01% | +42.9% |
| Q4 2014 | $50,532,000 | -23.9% | 949,668 | -32.8% | 0.01% | -22.2% |
| Q3 2014 | $66,442,000 | -37.9% | 1,413,968 | -17.7% | 0.01% | -35.7% |
| Q2 2014 | $107,044,000 | -4.4% | 1,718,486 | +3.2% | 0.01% | -12.5% |
| Q1 2014 | $111,974,000 | +27.9% | 1,664,786 | 0.0% | 0.02% | +33.3% |
| Q4 2013 | $87,568,000 | +21.5% | 1,664,786 | 0.0% | 0.01% | +9.1% |
| Q3 2013 | $72,052,000 | +57.7% | 1,664,786 | +36.3% | 0.01% | +57.1% |
| Q2 2013 | $45,693,000 | – | 1,221,086 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |